News Briefs

ActoGeniX

7 February 2007

ActoGeniX NV, a Belgium-based developer of an oral drug delivery platform, has raised

Join - PE HUB

Get access to regular updates from PE HUB

Email address

First name Last name Organisation Country Phone number Job title To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Nearly there!

ActoGeniX

NanoXplore closes private placement

ROC Partners amasses $120.15m for fourth Asia Pacific PE fund

B2B software assets embraced in work-from-home environment

Nearly there!

Share this:

RELATED ARTICLESMORE FROM AUTHOR

B2B software assets embraced in work-from-home environment

TSG Consumer closes deal for MSCP’s Pathway as vet care is deemed “essential business”

Industrial PE to reassess supply chain as pandemic reveals vulnerabilities

Join - PE HUB

Login

Sign in to your account

Nearly there!

We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it’s been delivered there.

NanoXplore closes private placement

ROC Partners amasses $120.15m for fourth Asia Pacific PE fund

B2B software assets embraced in work-from-home environment

RELATED ARTICLES MORE FROM AUTHOR